Endothelin 1-21 plasma concentrations in children and adolescents with insulin-dependent diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 9, Issue 4, 1996, Pages 463-468

  Malamitsi Puchner, A ^a,c   Economou, E ^b   Katsouyanni, K ^a   Karachaliou, F ^b   Delis, D ^b   Bartsocas, C S ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Adolescents; Angiopathy; Children; Endothelins; Insulin dependent diabetes mellitus; Plasma concentrations

Indexed keywords

ENDOTHELIN 1 DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIABETIC ANGIOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE;

EID: 0029813023     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1996.9.4.463     Document Type: Article

References (33)

1. Yangisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
2. + exchange, c-fos expression and mitogenesis in rat mesangial cells. J Clin Invest 1989; 83: 708-712.
3. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225-228.
4. Inoue A, Yanagisawa M, Kimura S, Kasuya M, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989; 86: 2863-2967.
5. Yanagisawa M, Masaki T. Endothelin, a novel endothelium derived peptide. Biochem Pharmacol 1989; 38: 1877-1883.
6. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T. The human preproendothelin-1 gene. J Biol Chem 1989; 264: 14954-14959.
7. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides and sodium-potassmm-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599-606.
8. Davidorf FH, Chambers RB. Diabetic retinopathy during pregnancy. Clin Perinatol 1993; 20: 571-581.
9. Gonzalez AM, Sochor M, Hothersall JS, McLean P. Effect of aldose reductase inhibitor (Sorbinil) on integration of polyol pathway, pentose phosphate pathway and glycolytic route in diabetic rat lens. Diabetes 1986; 35: 1200-1205.
10. Cohen RA. Disfunction of vascular endothelium in diabetes mellitus. Circulation 1993; 87 (Suppl V): V67-V76.
11. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma. FEBS Lett 1989; 245: 164-166.
12. Cernacek P, Stewart D. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Comm 1989; 161: 562-567.
13. Miyauchi T, Yanagisawa M, Tomisawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989; II: 53-54.
14. Tomita K, Ujiie K, Nakanishi T, Tomura S, Matsuda O, Ando K, Shichiri M, Hirata Y, Marumo F. Plasma endothelin levels in patients with acute renal failure. N Engl J Med 1989; 321: 1127.
15. Kaplan NM. Hormonal and local factors in hypertension. Am J Med Sci 1991; 301: 412-420.
16. Branch DW, Dudley DJ, Mitchell M. Preliminary evidence for homeostatic mechanism regulating endothelin production in pre-eclampsia. Lancet 1991; 337: 943-945.
17. Takahashi K, Ghatei MA, Lam HC, O'Hallavan DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990, 33: 306- 310.
18. Kanno K, Hirata Y, Shichiri M, Marumo F. Plasma endothelin-1 levels in patients with diabetes mellitus with or without vascular complication. J Cardivasc Pharmacol 1991; 17 (Suppl 7): S475-476.
19. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH. Increased plasma levels of endothelin in diabetic patients with hypertension Am J Hypertension 1992; 5: 161-166.
20. Veglio F, Bertello P, Pinna G, Mulatero P, Rossi A, Gurioli L, Panarelli M, Chiandussi L. Plasma endothelin in essential hypertension and diabetes mellitus. J Hum Hypertens 1993; 7: 321-325.
21. Malamitsi-Puchner A, Antsaklis A, Economou E, Mesogitis S, Papantoniou N, Koutra N, Aravantinos D. Endothelin 1-21 plasma levels in fetuses at 18-24 weeks of gestation. J Perinat Med 1995; 23: 321-325.
22. Malamitsi-Puchner A, Economou E, Efstathopoulos T, Hadzistamatiou Z, Nicolopoulos D. Endothelin 1-21 plasma concentrations on days 1 and 4 of life in healthy and ill preterm neonates. Biol Neonate 1995; 67: 317-321.
23. Malamitsi-Puchner A, Economou E, Sevastiadou S, Efstathopoulos T, Nicolopoulos D. Endothelin 1-21 plasma levels on the first and fourth postpartum day in normal fullterm neonates. Dev Pharmacol Ther 1993; 20: 195-198.
24. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Temma S, Matsumura M, Ueda T, Shirakami G, Imura H, Mikawa H. Plasma endothelin levels in healthy children: high values in early infancy. J Cardiovasc Pharmacol 1991; 17: (Suppl 7): 404-405.
25. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241: 2035-2038.
26. Jarett RJ, McCartney P, Keen H. The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycemic controls and risk indices for coronary heart diseases in borderline diabetics. Diabetologia 1982; 22: 79-84.
27. Cohen RA, Tesfamariam B. Diabetes mellitus and the vascular endothelium. In: Ruderman N, ed. Hyperglycemia. Diabetes and Vascular Disease. New York: Oxford University Press, 1992; 44-49.
28. Porta M, Selva ML, Molinatti P, Molinatti GM. Endothelial cell function in diabetic microangiopathy. Diabetologia 1987; 30: 601-609.
29. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
30. Boulanger CM, Luscher TF. Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587-590.
31. Cade C, Ilozue V, Rubanyi GM, Parker-Botelho LG. Smooth muscle cell factor responsible for decreasing big endothelin and endothelin produced by cultured endothelial cells. J Cardiovasc Pharmacol 1991; 17 (Suppl 7): 71-75.
32. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992; 263: H321-H326.
33. Wolff SP, Dean RT. Glucose autoxidation and protein modification: The role of oxidative glycosylation in diabetes. Biochem J 1987; 245: 234-250.